Levaquin sufferer.

February 8th, 2010

Another victim’s message:

I was on levaquinn for a pneumonia infection and the first night of taking it i was almost in the er i couldnt breath and had sever anxiety attack which ive never in my life had before.. i never had tendon problems but i have everything else..i cant ever fall asleep, really bad insomia..i couldnt breath and my arms are really shaky all the time it doesnt look shaky but i shake inside really bad its hard to explain the feelings i get.. my eyes twiched for about a week and stopped but its really scary i just want to be normal im only 23 i feel like im never gonna be myself again my neck is itchy and always red  and my left eye lid is always red i dont know what to do because nobody believes me not my parents or doctors

  • http://MyQuinstory.info
  • Levaquin Blog
  • http://FqHelp.com
  • http://lariaminfo.org
  • http://www.fqvictims.org
  • http://antibiotics.org
  • http://www.boiseweekly.com/gyrobase/Content?oid=310711
  • http://www.favc.info
  • ADR Central: Antibiotics, Lariam, Vaccines
  • Risperdal Kickback case.

    February 7th, 2010

    Risperdal Kickback Case.

    By Jim Edwards | Jan 18, 2010

    Executives at Johnson & Johnson (JNJ) saw ethical red flags in their relationship with Omnicare (OCR) as early as 1999, according to copies of their emails. One even contemplated the possibility of going to jail, the emails show.

    On at least four occasions between 1999 and 2004, J&J execs raised questions over whether their arrangement with Omnicare — in which J&J paid Omnicare millions in rebates if J&J’s drugs increased their market share among Omnicare’s nursing home patients — was ethical or legal, according to the emails and documents.

    On Jan. 15, 2010, the Department of Justice sued J&J, alleging that rebates for drugs such as the antipsychotic Risperdal were illegal kickbacks that artificially increased Omnicare’s annual purchases of J&J drugs from approximately $100 million to more than $280 million. Much of the purchases were reimbursed by Medicaid, the suit alleges, and J&J’s drugs made huge gains in market share as Omnicare, the dominant pharmacy supplier for nursing homes, pushed J&J brands at the expense of their competitors. J&J said in a statement:

    “We are reviewing the complaint filed today and will address the government’s lawsuit in court.  We believe airing the facts will confirm that our conduct, including rebating programs like those the government now challenges, was lawful and appropriate.  We look forward to the opportunity to present our evidence in court.”

    More than a decade earlier, on Sept. 13, 1999, J&J business group account director Bruce Cummins wrote a long email to his colleagues describing a tense series of negotiations with Omnicare (see page 252 of the complaint). The two companies had fallen out in part because Omnicare’s copy of the contract was missing pages when it was signed. The upshot was that Omnicare believed it was owed about $700,000 in rebates that it had not received. It was Cummins’ job to convince Omnicare that it was mistaken; only half of that sum was owed.

    Part of his argument was that if additional “overlays” were paid to Omnicare they may violate the contract, Cummins told his colleagues. “Based on the continuing scrutiny regarding abuse in our industry, we must follow contractual issues to the letter. No overlay’s will be paid for 97-98 or 98-99,” he wrote. However, Cummins indicated that Omnicare could be paid extra in other ways, “outside the JJHCS contract to see if anything can be done…”

    Cummins then went on to describe an angry exchange he had with Omnicare’s director of purchasing, Dan Maloney, in which the Omnicare man demanded money. Cummins told him, “I wasn’t going to go to jail for Dan, Omnicare, or for that matter J&J”:


    (Click to enlarge images.)

    Cummins’ position was backed by Martine Grant, a colleague within J&J’s Health Care Systems division. She had written to colleagues on May 19, 1999, that “going above the contract put us at risk for fraud and abuse”:

    On July 11, 2000, a solution was proposed. J&J would pay Omnicare “consultant services revenue” to replace the lost “overlay” money:

    A $750,000 contract was eventually signed in October 2000, according to the DOJ’s complaint (see page 276).

    That contract, however, triggered a new problem for J&J. Now that it was paying Omnicare the extra money, J&J had to make sure the performance on the contract was documented to make sure it met with their own compliance standards — and didn’t look like a kickback to make sure Omnicare promoted Risperdal. On July 22, 2002, Petro Thomas from J&J’s HCS group emailed his colleagues to warn them that they were “under heavy scrutiny from the corporate legal team” and that they should make up the rebates “in another way”:

    By September 2003, it became clear that to properly document the consulting contract, J&J would need to show what it received from Omnicare in return for its money. Charles Chartier, an account director at J&J, emailed his colleagues in a search for “any lists” Omnicare might have given J&J, even if only “randomly,” or if the information was written on “scratch pads”:

    The effort appeared to work, the emails show. In 2002, J&J’s Levaquin antibiotic saw a 19 percent share gain in five months. The reaction of one executive, informed of the news in an email was that it was “scary” that the company had such power:  

     

     

  • http://MyQuinstory.info
  • Levaquin Blog
  • http://FqHelp.com
  • http://lariaminfo.org
  • http://www.fqvictims.org
  • http://antibiotics.org
  • http://www.boiseweekly.com/gyrobase/Content?oid=310711
  • http://www.favc.info
  • ADR Central: Antibiotics, Lariam, Vaccines
  • Medical schools response to ghostwriting scandals.

    February 3rd, 2010

    Med schools not responding to ghostwriting scandals 

    The open access journal PLoS Medicine has been at the forefront of a closely related issue: full disclosure. In 2009, it was on the winning side of a suit that helped reveal the extent of ghostwriting in the biomedical literature. The practice, in which pharmaceutical companies pay for the production of a medical research article without the activity being disclosed, can distort the scientific record. Now, the journal has published a new study that indicates few of the top medical schools have any policy in place to govern ghostwriting among their faculty.

    Most medical journals recognize that industry-sponsored studies can suffer from conflicts of interest, and may selectively promote positive results or underplay the significance of negative ones. As a result, they generally demand that all authors of a paper disclose potential conflicts. This specific form of ghostwriting undercuts that process: since the writers aren’t credited, their conflicts never get listed. The new article cites specific instances where misleading results were ghostwritten in a way that minimized the issues with Vioxx and Paxil.

    So, how are medical institutions responding to this problem? For the most part, they’re not. The authors searched for policies regarding authorship and ghostwriting at the top 50 medical research centers and, in over half the cases, failed to find any, even after consulting research librarians at those institutions. Only 10 specifically prohibit ghostwriting, while another three have stringent authorship policies that effectively block its use.

    The authors make an impassioned argument that this must change, as they view ghostwriting as a public health threat, and one that violates academic norms. They call on deans of academic medical centers to explicitly ban the practice by the end of this academic year, and call on the National Institutes of Health to refuse to fund any research at institutions that refuse. It would be a radical measure, but the institutions are apparently not responding to repeated discoveries of unethical behavior, suggesting something radical might be needed.

    PLoS Medicine, 2010. DOI: 10.1371/journal.pmed.1000230

     

  • http://MyQuinstory.info
  • Levaquin Blog
  • http://FqHelp.com
  • http://lariaminfo.org
  • http://www.fqvictims.org
  • http://antibiotics.org
  • http://www.boiseweekly.com/gyrobase/Content?oid=310711
  • http://www.favc.info
  • ADR Central: Antibiotics, Lariam, Vaccines
  • Fluoroquinolone reaction comments.

    January 30th, 2010
    Fluoroquinolone comments sent to me from LG Lindsay.
    I think the hardest part of the ordeal is that fluoroquinolone poisoning leaves scant trace. Fluoroquinolone poisoning strips away both health and personal credibility. With the exception of its direct tie to damage at the tendons and Achilles heal, Fluoroquinolone poisoning is hard to verify independently, and doctors regard the malaise in the same way doctors historically have condescended to Epstein-Barr and fibromyalgia.
     
    I think the heart of my argument is that it’s unethical for a business to meet its sales and profit projections while deliberately downplaying the danger of its product. No merchant should reap a financial bonanza while holding the marketplace in the dark re: his product’s inconsistent outcome and potential for permanently disabling an unwitting buyer.  It is clear to fluoroquinolone antibiotic sufferers that we have been bamboozled, but it’s not a sure bet we can convince the shibboleths of society that every medical consumer is at risk before the misleading representations by unfettered pharmaceutical companies bent upon maximizing their profits. The metaphor of playing Russian roulette with one’s health is not appropriate:  Every chamber in big pharma’s six-shooter is loaded with pharmaceutical bullets.
     
    We swarmed our doctors’ offices with non life-threatening ailments and we exited the doctors’ offices as basket cases who subsequently bore ridicule and derisiveness for even suggesting that our doctors’ prescriptions turned non life-threatening into life-theatening.      
     
    What turns my crank is we must approach floxies-malaise as if we were trying to convince a skeptical public about the existence of the Lochness Monster or big foot. It’s preposterous that thousands of the floxed must point out big pharma’s hand in fluoroquinolone poisoning as if they were describing an invisible, but omnipresent graphitti-ist who defaces postal boxes around the country. Everyone has seen graphitti, but no-one can identify the culprit whose distinctive broad brush strokes sully rich neighborhoods and poor barrios alike. Based on the medical industry’s deafening silenence you’d think fluoroquinolone poisoning were a gauzy hoax about mythical unicorns, Wolfman or, say, flying saucers in H G Wells’ War of the Worlds.  In order not to endanger its hundreds of millions in profits big pharma wraps itself in legal constructs about “limited liability” and buries flawed research trials in file cabinets marked “Eyes Only- trade secrets.”    
     
    Our society has become so complex that only large corporations have the umphf and technical know-how to advance their agendas on behalf  of shareholders whose motivation is solely pecuniary gain. 
     

     

  • http://MyQuinstory.info
  • Levaquin Blog
  • http://FqHelp.com
  • http://lariaminfo.org
  • http://www.fqvictims.org
  • http://antibiotics.org
  • http://www.boiseweekly.com/gyrobase/Content?oid=310711
  • http://www.favc.info
  • ADR Central: Antibiotics, Lariam, Vaccines
  • Life of hell.

    January 2nd, 2010

    Our life was Hell because of Levaquin”News

    September 23, 2008. By Jane Mundy

    Mineral Point, WI: “My husband just walked to his truck and heard two big ‘pops’,” says Lifka.”He blew out the quads in both legs and went down.” Chuck had been taking the antibiotic Levaquin for a respiratory infection; nobody told him about Levaquin side effects. “By the time I found him, Chuck had almost frozen to death—it was February in Wisconsin.”

    Chuck was in excellent shape: he builds houses and coaches football. Lifka says he wasn’t working or involved in any athletic events at the time this happened. Instead, Chuck was getting over the bacterial infection—the reason he was prescribed Levaquin medicine, which he had taken for 8 days. Because of his coaching experience, Chuck knew what had happened right away.

    Levaquin Victim“I saw his truck in the driveway but I couldn’t find him,” says Lifka, “then I went outside and looked over my deck and saw him laying there in the snow. Through his jeans I could see the bulges of muscle on both sides of his legs; they had completely separated from his knee cap. By the time the ambulance came, his water bottle was frozen.

    “Our local hospital wasn’t qualified to do anything so Chuck was transferred to a hospital in Madison, about 40 miles away, where he was able to see a specialist. A few doctors looked at him, ran some tests and x-rays were taken. Both quads were completely ruptured. The prognosis: he was a case study. The specialist had an opening the following week and surgery was scheduled.

    Meanwhile Chuck came home with me in a wheelchair and he had locked braces that went from his groin to ankle so no movement was possible. And he had lots of pain killers, including Oxycontin—that is a whole other story. Chuck is 6′ 4″ and 230 lbs so we couldn’t even get him and the wheelchair into the house. Our life was hell and it still is…

    The surgery was beyond horrible. They had to saw into his kneecap, take that muscle and wrap it into the opening, bring it through the knee and re-attach muscle to muscle by looping it through his kneecap. And they drilled holes in the sides of his kneecaps so no pressure would be put on those muscles until rehab kicked in. Chuck was in hospital a few days, followed by intense rehab until this past July—he had to learn how to walk all over again.

    Chuck wasn’t doing anything physical when this happened. What could have caused these ruptures? Our specialist said it was bizarre, that none of it made sense. Then we mentioned Levaquin to him and he was very cautious in his reply; in fact he avoided the topic. Then I looked on the Internet…

    Chuck is only 46 but when this happened, he lost all his muscles, his face was gray and he looked decades older. He is working hard at recovery but will never be normal.

    ‘My future is done,’ Chuck said to me just the other day. ‘I’m going to be more handicapped the older I get.’ Chuck is in pain all the time. He certainly can’t go back to working at the level he did and house building was our livelihood. Now we just take it day by day, that’s all you can do. And now he suffers with depression; he can’t sleep because of the pain and our lives are full of anxiety. Our kids can’t understand the pain he suffered or the drugs he was on–that was horrific. It was so painful for us to see him suffer so much.

    I am absolutely furious that this happened. We should be informed about any drug on the market and have a choice: when you are uninformed by the health community and something like this happens, you are so helpless.

    People need to know about this whole group of drugs; the medical field must let us know. And it is happening to so many people, it has to stop. We are from a little town and appreciate our doctor and pharmacist; I don’t even think they were informed so it has to start with the drug company: they are responsible. We didn’t even know about a black box warning until I researched Levaquin lawsuits on the Internet.

    I just hope we can help others to become aware of this drug. And get some legal help: we had so many dreams and plans; what did Chuck do to deserve this? All because nothing was told to us about Levaquin’s side effects.”

  • http://MyQuinstory.info
  • Levaquin Blog
  • http://FqHelp.com
  • http://lariaminfo.org
  • http://www.fqvictims.org
  • http://antibiotics.org
  • http://www.boiseweekly.com/gyrobase/Content?oid=310711
  • http://www.favc.info
  • ADR Central: Antibiotics, Lariam, Vaccines
  • MyQuinStory.info Life after Levaquin. A challenging journey.

    January 1st, 2010

    Here is a new quinolone website from a Levaquin victim named David. He was a healthy middle aged man severely injured from taking Levaquin. Wishing him and all the other quinolone victims a healthier and happier year in 2010.   

    www.MyQuinstory.info

     

      

  • http://MyQuinstory.info
  • Levaquin Blog
  • http://FqHelp.com
  • http://lariaminfo.org
  • http://www.fqvictims.org
  • http://antibiotics.org
  • http://www.boiseweekly.com/gyrobase/Content?oid=310711
  • http://www.favc.info
  • ADR Central: Antibiotics, Lariam, Vaccines
  • Lariam’s Psychotic side effect’s. 60 Minutes II

    December 23rd, 2009

    Lariam’s Psychotic Side Effects?
    CBSNEWS.COM, 60 Minutes II,
    Jan. 29, 2003

    Last summer, four soldiers from Ft. Bragg were accused of killing their wives. Two of the men committed suicide, and the other two await trial. So many brutal crimes, so similar, so close in time – raised questions, and the army sent a team to investigate.

    One possible suspect was mefloquine - brand name Lariam, an anti-malarial drug. It was invented by the U.S. Army and is routinely given to soldiers deployed overseas. In scientific terms, Lariam can cause neuropsychiatric adverse events. In plain language, it can make you crazy. No one questions Lariam’s effectiveness in preventing the deadly disease of malaria. Millions of tourists and other world travelers take it every year with no problem.

    But a significant number of people have seen and felt first hand its devastating side effects. Vicki Mabrey reports.

    It was supposed to be a dream vacation, a safari to Kenya last September for Dr. Robert Daehler and his wife Jane, seen here on home video. What you won’t you see is how, deep in the African bush, she suddenly transformed before his eyes.

    “She just became completely psychotic in the van,” says Bob. “(She”) started taking her clothes off and she had called people back from the dead. And they had a doctor at this lodge that came into the van. And she looked at Jane and she said, ‘Did she take Lariam?’ She said she had seen this in many Americans.”

    So had three other doctors in Africa, who confirmed the diagnosis. Jane Daehler was flown home, strapped to her seat with a bedsheet. At home, she spent a month in a psychiatric hospital, in and out of psychosis, with terrifying hallucinations. At the U.S. hospital, she was diagnosed with Lariam-induced psychosis.

    “They were just horrific. I thought that people were trying to kill me all the time. I thought that my family was going to be killed,” says Jane.

    According to its own internal documents, Roche pharmaceuticals, Lariam’s maker, has received over 3,000 reports of psychiatric problems associated with the drug, from nightmares, depression and hallucinations to paranoia, psychosis and aggression.

    But could Lariam lead to something worse? That was the question raised last summer when this man, Master Sgt. William Wright and three other Ft. Bragg soldiers were accused of killing their wives, all within a period of just under six weeks. Wright and another soldier were given Lariam, and Wright is considering using that as part of his defense. One of his fellow Green Berets thinks Lariam did play a role. John Lown, now an ordained minister, visits Wright in jail every week.

    At first, Lown says, Wright was “very confused, he was very paranoid, and I was like ‘Wow this is not the Bill that I knew.’… About the fifth week after that, he was, he was coherent. He was fine. He even said, ‘Well, I’m thinking a lot better now.’”

    What does Lown think caused his change? “I think it was the medication. It took about two months for the stuff to clear out of your system.”

    Lown and his unit had names for the days they took Lariam: “Everybody would call it manic Mondays or wild Wednesdays.”

    His wife, Debbie, says she’d see an immediate change when he was on Lariam: “He just turned ugly towards me… And when I mentioned that to other wives, they said that’s the way their husbands are as well.”

    The other wives told her that while on Lariam, their husbands “were very negative, aggressive. Couple of them even complained how they’d be woke up in the middle of the night, shook, be called names. One running down the street without his clothes on, hollering, screaming.”

    How do she know it just wasn’t the stress of the job? “He’s been on other deployments where Lariam was not required and he didn’t have these kind of problems,” says Debbie.

    Like her husband, Debbie Lown is convinced Lariam was a factor in some of the Ft. Bragg murders. She had even complained to military authorities as far back as 1996.

    “I said, ‘I’m not asking you to stop giving them the Lariam. I’m just asking you to better inform the soldiers of what they’re taking, tell their wives, because they’ll save marriages that way, they’ll save lives that way,’” she recalls.

    Jane Daehler agrees that knowing it was the Lariam can make all the difference. “If it wasn’t for (my husband), I honestly think that somebody could have put me in a mental institution and thrown away the key.”

    Before the trip, her husband, a physician, says he was careful, since his wife had been treated for depression in the past and was on what he says was a low, preventative dose of Prozac. He checked with a travel clinic, the Centers for Disease Control website, and his physicians drug guide.

    The information was written by drug companies for doctors and approved by the Food and Drug Administration. The key part is the warning section: “Lariam should not be prescribed in patients with active depression or with a history of psychosis or convulsions.”

    “That’s what I read,” says Bob. “And Jane did not have active depression. She did not, it was 10 years earlier. She did not have psychosis ever. She never had seizures…. Nor did I. There was no reason why either of us couldn’t take this drug.”

    But what was not in the warning section, what may have raised a red flag for the Daehlers are these disturbing side effects, depression, hallucinations, psychotic or paranoid reactions, aggression, all listed towards the end.

    “They buried the lead. They took the important information that would’ve tipped off a doctor, and stuck it down there in a part that’s not part of the warnings,” says attorney Bernard Fischman, who represents the Daehlers in a lawsuit they’ve filed against Roche. Fischman argues that the company failed to properly warn them.

    Can’t Roche argue, that the information is there? “It doesn’t call any attention to the real nature of this problem. There’s no mention of psychiatric problems under the warning section of that package insert,” says lawyer Paul Smith, who is also representing the Daehlers.

    “There’s alternatives that can be taken, there’s just no reason that americans should be taking Lariam,” says Bob Daehler.

    Doxycycline, a common antibiotic, and malarone, approved two years ago, are both effective in preventing malaria and have fewer psychiatric side effects than Lariam.

    Roche, the drug company, claims that Lariam causes serious psychiatric side effects in only one in 10,000 people. But Dr. Paul Clarke, an infectious disease specialist and the medical director of a large network of travel clinics in Great Britain, organized his own study, after he and other British doctors saw problems with much greater frequency.

    “It was confusion, it was disorientation, it was anxiety and panic attacks,” says Clarke. “There were episodes in which people were clearly divorced from reality and indeed had unusual symptoms that could be described as psychotic.”

    Their research confirmed the hunch. Not one in 10,000, but closer to one in a 140 suffered disabling side effects, defined as substantially disrupting their lives - the same kinds of side effects that Dr. Clarke had seen in his patients.

    Why such a huge difference in the numbers? Because of the key difference between the term “disabling” in Dr. Clarke’s study and the term “serious” as used by the drug company. In Roche’s study, serious meant you had to be dead, in the hospital or have a long-term disability to count. It’s an industry standard all drug companies use, but with that narrow definition, Dr. Clarke says, Roche’s study may have failed to identify up to seventy times more patients with troubling side effects.

    Based in part on Dr. Clarke’s study, British authorities began to recommend using Lariam less often. Despite his concerns, though, he still says Lariam can be a useful drug.

    “It’s very easy to take once a week, it gives you very good protection, you get good compliance. And if you’ve taken it in the past and never had a problem with it I, for one, would be very sorry to see it go, because it’s a good drug,” he says. He only wants people to be better informed.

    60 Minutes II ask both the FDA and the CDC about how well the American public is informed of Lariam’s potential dangers. But both government agencies chose not to do an interview. The FDA did send a statement, saying that Lariam’s benefits far outweigh its risks.

    Roche also declined a request for an interview, but sent a statement saying, in part, that no prescription drug is free of side effects.

    Roche also said there’s no way for a physician to predict every person at risk for psychiatric side effects. Linda Perry considers her husband a perfect example of that.

    In 1998, Linda and Chuck Perry left their Midwest ranch and their seven children to go on an African safari for their 30th wedding anniversary. Linda, a registered nurse, checked with her doctor, her pharmacist, and the local health department. For malaria protection, they all recommended Lariam.

    “The first warning I ever got was from the safari guide in Africa,” says Linda. “She says to me, ‘Well, why do you take Lariam?’ It’s a hallucinogen very much like LSD.’ And I said, ‘the CDC recommends it.’ And she said, ‘Well, we never take it.’”

    After four doses of Lariam, the Perrys were having night sweats and vivid nightmares. But everyone, including the CDC, had stressed taking the full dose of the drug, which meant taking it for four weeks after the trip. That’s when Chuck Perry’s real problems began.

    Perry: Didn’t know where he was. I mean, he ran out in the yard. I can remember tackling him in the yard saying, “what are you doing? What are you doing?” you know. “the neighbors are after me, somebody’s after me.” And it was just bizarre, just– just bizarre.
    mabrey: You had never seen anything like this from him before?
    Linda Perry: Nothing. He’s the rock of the earth, salt of the earth.

    Linda Perry says her husband had no prior history of depression or mental illness. Chuck Perry was hospitalized and tested repeatedly. A team of doctors became convinced that Lariam was responsible. Linda says that the doctors didn’t know how to help him.

    Six months after returning home from Africa, Chuck Perry committed suicide.

    “We had no way to know that this drug would be so powerful that it could alter his personality so much and damage him so much that he would, in fact, do that in some type of delusion or hallucination. That’s what we didn’t know,” says Linda Perry.

    But Roche did know something about Lariam and suicide. Over the past year, two UPI reporters, Dan Olmsted and Mark Benjamin, unearthed these internal documents. They show that by the time Chuck Perry killed himself, the company knew of at least seven suicides, and 13 suicide attempts, by people living outside the United States - all associated with Lariam. But nowhere in its product information was there any mention of the word suicide.

    After two years of trying to attribute Chuck Perry’s suicide to other causes, Roche settled a wrongful death suit with Linda Perry last May.

    Two months later, Roche dramatically changed its product information. Psychiatric side effects are now in the warning section, including, for the first time, rare cases of suicide.

    But Roche says there is no proof linking its drug to suicide, and points out that Chuck Perry is the only reported American suicide of the more than five million who have taken Lariam in the U.S. that doesn’t address the other suicide reports outside the united states, but Roche says those cases are well below the suicide rate in the general population. When we requested current figures, Roche declined, saying that accurate numbers on all reported events are hard to come by.

    Dr. Paul Clarke: What is not clear is, how many people may have been permanently damaged, if any, or indeed may have gone as far as a psychotic episode, which might’ve led to some other ghastly accident.

    But could it have led to murder at Ft. Bragg? In early November, the army released its findings, which said that Lariam, in the army’s words, does not explain the clustering of violent deaths there. As a result, the military probably won’t change its policy on Lariam’s use.

    Should it be given to soldiers with guns? Says Clarke: “I would not give it to them. Because we do have alternatives and we do know they’re effective.”

    Unlike the U.S., Great Britain, Germany and Australia did not give their soldiers Lariam in Afghanistan, opting instead for those alternatives. But as the United States prepares for the possibility of war with Iraq, some of our American troops are already being given Lariam.
     

  • http://MyQuinstory.info
  • Levaquin Blog
  • http://FqHelp.com
  • http://lariaminfo.org
  • http://www.fqvictims.org
  • http://antibiotics.org
  • http://www.boiseweekly.com/gyrobase/Content?oid=310711
  • http://www.favc.info
  • ADR Central: Antibiotics, Lariam, Vaccines
  • CT Scans. Benefits and Risks

    December 16th, 2009

    (See Corrections & Amplifications item below.)

    The risk of cancer associated with popular CT scans appears to be greater than previously believed, according to two new studies published Monday in the Archives of Internal Medicine.

    The findings support caution against the overuse of CT scans and other medical technologies that use radiation. The studies also bolstered the rationale behind controversial new breast-cancer screening guidelines, which pushed back the recommended age for annual mammograms to 50 from 40. Mammograms also use radiation, but in smaller doses.

    Bloomberg News

    An imaging specialist looks on as a patient, behind window, undergoes a CT scan Aug. 6 at Falmouth Hospital in Falmouth, Mass.

    The CT — short for computerized tomography scan — can detect injuries and tumors. Its use has tripled in the U.S. since the early 1990s to more than 70 million in 2007. Though it has long been known that radiation increases a person’s chance of getting cancer, the exact risk of these scans wasn’t clear.

    One of the studies, which examined more than 1,000 adult patients at four hospitals, projected that the dose of radiation received in a single heart scan at age 40 would later result in cancer in 1 in 270 women and 1 in 600 men.

    Risks were lower for those who received a head CT scan: 1 in 8,100 women and 1 in 11,080 men would likely develop cancer from the radiation, the study said.

    Doses of radiation from the scans varied wildly, according to the study, even within the same procedure at the same hospital.

    Some patients got only one-tenth the radiation that others got, according to Rebecca Smith-Bindman, the first author on the study and a professor of radiology and biomedical imaging and epidemiology and biostatistics at the University of California San Francisco.

    [Chart]

    The findings raise questions about why radiation doses differ, and whether the variation is acceptable. “These are doses we should be concerned about,” said Dr. Smith-Bindman. “They don’t have to be this high.”

    The variation in radiation exposure for any particular CT procedure is likely due to such factors as a lack of standardized settings, and differences in how the radiologists and technologists use the technology for different patients, according to Dr. Smith-Bindman.

    A radiation dose that is too low, for example, could yield a picture that isn’t clear enough to reveal abnormalities.

    The second study analyzed data from several databases and estimated that 29,000 future cancers could be related to CT scans received in 2007, with the greatest number of cancers projected in the abdomen and pelvis.

    The cancer risk was greatest for young patients, this study found. For instance, a female who received an abdominal scan at age 3 had a 1 in 500 chance of developing cancer because of the radiation from that scan. That figure dropped to 1 in 1,000 by age 30, and 1 in 3,333 at age 70.

    Overuse of radiation-based tests is a concern when they are performed to diagnose patients who have a known abnormality. But the concern is even greater when they are performed for screening purposes, said Amy Berrington, an investigator at the National Cancer Institute and an author on both papers. “You’re exposing a lot of healthy people” to radiation,” she said.

    The doses of radiation received from mammograms are much smaller than from CT scans, yet the small cancer risk should be weighed when deciding whether to undergo routine breast-cancer screening, Dr. Berrington said.

    In loosening the mammogram guidelines last month, a federally funded task force of physicians cited, among other factors, the potential harm from testing.

    Despite these concerns, CT scans provide “great medical benefit,” she said. “On an individual basis, if the scan is justified, then the benefits should outweigh the risks.”

  • http://MyQuinstory.info
  • Levaquin Blog
  • http://FqHelp.com
  • http://lariaminfo.org
  • http://www.fqvictims.org
  • http://antibiotics.org
  • http://www.boiseweekly.com/gyrobase/Content?oid=310711
  • http://www.favc.info
  • ADR Central: Antibiotics, Lariam, Vaccines
  • Levaquin patients face serious risks.

    December 6th, 2009

    Levaquin Patients Face Serious Risks

    October 12, 2009. By Heidi Turner

    Boise, ID: Patients who take Levaquin to treat infections run a risk of developing Levaquin side effects, including Levaquin tendon ruptures. Unfortunately, many patients say they had no idea there was even a possibility of tendon ruptures associated with taking the Levaquin medication. Now, they are left dealing with the recovery, which can include tendon surgeries, more medication and rehabilitation.

    Levaquin Patients Face Serious RisksThe truth is that many people would probably not consider tendon rupture to be a side effect of medication—especially medication for something as simple as an infection. But Levaquin has reportedly been linked to an increased risk of tendon ruptures. These ruptures are incredibly painful and can have a major impact on a person’s day-to-day life.

    Such tendon ruptures include the Achilles tendon, which can impair a person’s ability to walk. Others impact tendons in the arms or other tendons in the legs, also having an impact on mobility and ability to work. After all, it is virtually impossible to carry out any tasks if a person’s dominant hand cannot be moved or if he cannot move like he normally would.

    Some patients have written to LawyersandSettlements about their ordeals since they took Levaquin to treat infections. Their names have been withheld, but other patients might just relate to their stories.

    “I was prescribed Levaquin several months ago for an infection,” Ryan writes. “A couple of days ago, the Achilles tendon in my left foot became inflamed, with the sudden and severe pain. I did not have any trauma to account for the symptoms. I have had difficulty walking and have lost a considerable amount of the range of motion in my left foot. The swelling is severe and my family physician is trying to get me an appointment with a specialist orthopedic surgeon to evaluate the extent of my injury. Due to the unusual swelling pattern, the tendon is probably ruptured.”

    “I have severe tendonitis as a result of taking levaquin for seven days,” Renee writes. “It has been eight weeks since this started and [I have been through] several doctor visits including two trips to the hospital. My foot is still as swollen as it was eight weeks ago and I am in pain with every step I take.”

    Patients are concerned that they may suffer with the pain for the rest of their lives. At the very least, some patients require surgery and extensive rehabilitation to recover their range of motion and get their tendons working properly again. Even with surgery and rehabilitation, the patients generally face long recovery times, with multiple doctor’s appointments to set things right.

    All this because they had an infection to treat.

  • http://MyQuinstory.info
  • Levaquin Blog
  • http://FqHelp.com
  • http://lariaminfo.org
  • http://www.fqvictims.org
  • http://antibiotics.org
  • http://www.boiseweekly.com/gyrobase/Content?oid=310711
  • http://www.favc.info
  • ADR Central: Antibiotics, Lariam, Vaccines
  • Drugs and Death at Bagram. Anti-Malarial medication. Lariam Toxicity

    December 4th, 2009

    Drugs and Death at Bagram movie trailor.  

    Unfortunately, some of the families that that try and investigate the facts end up being investigated themselves. 

    http://drugsanddeathatbagram.com/

     

  • http://MyQuinstory.info
  • Levaquin Blog
  • http://FqHelp.com
  • http://lariaminfo.org
  • http://www.fqvictims.org
  • http://antibiotics.org
  • http://www.boiseweekly.com/gyrobase/Content?oid=310711
  • http://www.favc.info
  • ADR Central: Antibiotics, Lariam, Vaccines

  • Hosted by CTI Networks, Inc.